These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4290000)

  • 1. Studies on the neutralization of herpes simplex virus. IV. Properties of virus sensitized with complement-requiring neutralizing (CRN) antibody at 37 degrees and 0 degrees.
    Yoshino K; Taniguchi S
    Virology; 1967 Feb; 31(2):260-7. PubMed ID: 4290000
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the neutralization of herpes simplex virus. VII. Reevaluation of the equilibrium theory concerning the unneutralizable persistent fraction.
    Ide K; Yoshino K
    Jpn J Microbiol; 1974 Sep; 18(5):397-406. PubMed ID: 4374567
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the neutralization of herpes simplex virus. X. Demonstration of complement-requiring neutralizing (CRN) and slow-reacting CRN (s-CRN) antibodies in late IgG.
    Yoshino K; Isono N; Tada A; Urayama M
    Microbiol Immunol; 1979; 23(10):975-85. PubMed ID: 229389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late 19S rabbit antibody neutralization test for differentiating herpes simplex virus types 1 and 2.
    Hampar B; Martos LM; Chakrabarty M; Burroughs MA
    J Immunol; 1970 Mar; 104(3):593-8. PubMed ID: 4314178
    [No Abstract]   [Full Text] [Related]  

  • 5. A micro-neutralization system for detection of s-CRN antibody to herpes simplex virus.
    Yoshino K; Abe K
    Microbiol Immunol; 1981; 25(10):1037-46. PubMed ID: 6273697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Type-specificity of slow-reacting complement-requiring neutralizing antibody (s-CRN antibody) to herpes simplex virus types 1 and 2 in rabbits].
    Sekine N
    Uirusu; 1983 Jun; 33(1):47-55. PubMed ID: 6316659
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the neutralization of herpes simplex virus. VIII. Significance of viral sensitization for inactivation by complement.
    Yoshino K; Hashimoto M; Shinkai K
    Microbiol Immunol; 1977; 21(4):231-41. PubMed ID: 195185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the neutralization of herpes simplex virus. XI. Differences between slow-reacting complement-requiring neutralizing (s-CRN) antibodies in IgG and IgM.
    Yoshino K; Urayama M; Abe K
    Microbiol Immunol; 1980; 24(11):1069-77. PubMed ID: 6261091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of antibodies to herpesvirus types 1 and 2 in human sera.
    Rawls WE; Iwamoto K; Adam E; Melnick JL
    J Immunol; 1970 Mar; 104(3):599-606. PubMed ID: 4314179
    [No Abstract]   [Full Text] [Related]  

  • 10. Neutralization of sensitized virus by the fourth component of complement.
    Daniels CA; Borsos T; Rapp HJ; Snyderman R; Notkins AL
    Science; 1969 Aug; 165(3892):508-9. PubMed ID: 4183180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further analysis of physiochemical and immunologic properties of herpes simplex vus precipitating antigens.
    Tokumaru T
    Arch Gesamte Virusforsch; 1970; 29(4):295-306. PubMed ID: 4315820
    [No Abstract]   [Full Text] [Related]  

  • 12. Differentiation between herpes simplex virus type 1 and type 2 strains by immunoelectroosmophoresis.
    Jeansson S
    Appl Microbiol; 1972 Jul; 24(1):96-100. PubMed ID: 4341522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of growth of herpes simplex virus in chick embryo fibroblasts at 40 degrees C.
    Yoshino K; Taniguchi S; Takeuchi H
    Jpn J Microbiol; 1968 Mar; 12(1):97-102. PubMed ID: 4299895
    [No Abstract]   [Full Text] [Related]  

  • 14. Inflammation and viral infection: chemotactic activity resulting from the interaction of antiviral antibody and complement with cells infected with herpes simplex virus.
    Snyderman R; Wohlenberg C; Notkins AL
    J Infect Dis; 1972 Aug; 126(2):207-9. PubMed ID: 4340929
    [No Abstract]   [Full Text] [Related]  

  • 15. Neutralization of sensitized virus by purified components of complement.
    Daniels CA; Borsos T; Rapp HJ; Snyderman R; Notkins AL
    Proc Natl Acad Sci U S A; 1970 Mar; 65(3):528-35. PubMed ID: 4315612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of small plaques by herpes viruses irradiated with ultraviolet light.
    Ross LJ; Wildy P; Cameron KR
    Virology; 1971 Sep; 45(3):808-12. PubMed ID: 4331109
    [No Abstract]   [Full Text] [Related]  

  • 17. STUDIES ON THE NEUTRALIZATION OF HERPES SIMPLEX VIRUS. 3. MECHANISM OF THE ANTIBODY-POTENTIATING ACTION OF COMPLEMENT.
    YOSHINO K; TANIGUCHI S
    Virology; 1965 May; 26():61-72. PubMed ID: 14293314
    [No Abstract]   [Full Text] [Related]  

  • 18. Preparation of a stable noninfective diagnostic antigen for herpes simplex prepared from chick embryo tissue cultures.
    Guerin MM; Polley JR
    Can J Microbiol; 1970 Feb; 16(2):53-6. PubMed ID: 4313772
    [No Abstract]   [Full Text] [Related]  

  • 19. Type-specific protein in herpes simplex virus envelope reacts with neutralising antibody.
    Powell KL; Buchan A; Sim C; Watson DH
    Nature; 1974 May; 249(455):360-1. PubMed ID: 4135313
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on the heterogeneity of herpes simplex virus by means of immunodiffusion].
    Garcia JM; Bonifas VH
    Arch Gesamte Virusforsch; 1970; 31(1):125-36. PubMed ID: 4319861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.